Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study

PURPOSE: Results from large scale cardiovascular outcome trials in patients with type 2 diabetes mellitus (DM2) have found that sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce cardiovascular death and hospitalization for heart failure, but the mechanisms behind the beneficial cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Suhrs, Hannah Elena, Nilsson, Malin, Bové, Kira Bang, Zander, Mette, Prescott, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836314/
https://www.ncbi.nlm.nih.gov/pubmed/35148357
http://dx.doi.org/10.1371/journal.pone.0263481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836314/
https://www.ncbi.nlm.nih.gov/pubmed/35148357
http://dx.doi.org/10.1371/journal.pone.0263481

Ejemplares similares